Overview
Printcare supplies specialised printing, packaging and digital media products across Sri Lanka and export markets, with operations including corrugated packaging in East Africa and capacity in India. The September quarter restored an operating profit after a loss a year earlier, but finance costs and other charges still left the group in loss.
Price performance
At LKR 37.70 on 12 November 2026, the share had fallen 7.9% over three months while the ASPI gained 2.9%, consistent with the gap between improving operations and weak share performance. It has also lagged the ASPI across the reported one-week to one-year windows.
The price sits only 17.6% up its 52-week range, while 60-day volatility is above its own yearly norm and recent trading volume is below its 60-day norm. The three-year record includes a deep decline that has not recovered. Liquidity is exceptionally thin: a LKR 1 million order is more than everything that trades on a typical day (1137% of it).
Valuation
The P/B of 0.58 means the market price is 58 cents for each rupee of latest reported net assets, versus a manufacturing-sector median of 1.84 times. It is at the 4th percentile of 29 comparable peers, so the shares are priced well below sector book-value multiples.
The same measure is cheaper than 89% of days since February 2012, making the discount unusually deep in Printcare's own record. However, the latest audited return on equity was -22.3%, so the low P/B reflects a business that is currently eroding owners' capital rather than generating a positive return on it. P/E is not meaningful because trailing earnings are negative, and no dividend is on record in the last two years.
News and sentiment
Coverage was normal rather than unusually loud, with four material articles in the last 90 days and all classified neutral. The central development is the confirmed rights issue, declared on 15 September and updated on 28 October, offering 19 shares for every 70 held at LKR 30 per share.
The rights issue has an ex-date of 17 November 2026. Reported proceeds are intended for investment and working capital, but the new ordinary shares also change the per-share claim of investors who do not take up their entitlement.
Financials
September-quarter revenue rose 30.4% year-on-year, and operating profit turned positive. Gross margin was 14.3% versus 15.6% a year earlier, operating margin was 1.7% versus -2.2%, and net margin was -3.1% versus -6.9%. The gross margin was the worst of eight comparable September quarters, showing that the operating improvement came despite weaker production-level profitability.
The net loss narrowed by LKR 94.6 million to LKR 135 million, but LKR 210 million of finance costs, tax and other below-operating items exceeded operating profit. In plain terms, the core business made money in the quarter but charges outside operations absorbed more than it earned.
Equity fell to LKR 5.1 billion from LKR 6.6 billion a year earlier, reducing the asset backing behind the shares. The ordinary share count was broadly unchanged over the comparison, so this erosion is not a mechanical consequence of a larger existing share base.
Risks
The foremost risk is leverage. Total debt was LKR 11.5 billion at March 2026, with gearing of 204.7%, meaning debt was just over twice the equity attributable to ordinary owners. Operating profit did not cover the interest bill, with interest cover at -0.79 times, so lenders are being paid from a business that was still loss-making over the audited year.
The current ratio was 1.18 times, meaning short-term assets, including inventories and customer receivables, exceeded bills due within a year only narrowly. Free cash flow was negative LKR 1.5 billion, adding pressure where debt has risen.
Minority interests accounted for 32.6% of the annual group loss. Group profit and loss therefore does not map fully to the ordinary shares being valued. Manufacturing conditions are also mixed, while the November fuel-price increase raises transport and energy costs across the sector.
Outlook
As at 12 November 2026, the immediate company event is the 17 November rights ex-date. The rights issue can add funds for working capital and investment, while increasing the number of ordinary shares in issue.
The next financial test is the December 2026 interim quarter, expected to be filed between 4 and 14 February 2027. It should show whether the September return to operating profit persists and whether finance costs continue to outweigh it; current data cannot establish either outcome.